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Introduction
The leukemia B cells of patients with chronic lymphocytic leukemia (CLL) can be classified into one of at least two major subgroups based upon the mutational status of their expressed immunoglobulin (Ig) variable (V) genes 1, 2 . Patients with CLL cells that express non-mutated genes tend to have a relatively aggressive clinical course when compared with patients who have CLL cells that express Ig V genes with somatic mutations [2] [3] [4] . Moreover, patients with leukemia cells that express non-mutated Ig V genes generally are more likely to have CLL cells with atypical morphology, advanced clinical stage, and progressive disease 3 . However the mechanism(s) accounting for the differences in clinical behavior of these two types of CLL is unknown.
Recent studies on the gene expression profiles of isolated CLL B cells have revealed a set of genes that is differentially expressed between these two subgroups 5, 6 . The functional significance of ZAP-70 gene expression in this subgroup of CLL B cells is unknown. ZAP-70 is a PTK that is characterized by two tandem SH2 domains and a C-terminal catalytic domain 7, 8 . Following ligation of the T cell receptor (TCR), For personal use only. on September 14, 2017 . by guest www.bloodjournal.org From there is activation of src family PTK that in turn phosphorylates tyrosine-containing immunoreceptor tyrosine-based activation motifs (ITAMs) within the cytoplasmic tails of the accessory molecules of the TCR 9 . ZAP-70 is recruited to the phosphorylated ITAMs and subsequently becomes activated, in turn causing activation of Tec family PTKs and downstream signaling pathways, such as the phospholipase C /Ca 2+ signaling pathway and the Ras/mitogen activated protein kinase (MAPK) pathway 10 . B cells generally lack ZAP-70, but instead use another related PTK, Syk, for signal transduction via the B cell receptor (BCR) complex 11 . Similar to ZAP-70, Syk is recruited to the phosphorylated ITAMs of the activated BCR complex where it subsequently becomes activated 12 . As such, ZAP-70 and Syk play similar roles in membrane antigen-receptor signaling pathways.
Prior studies indicated that ZAP-70 could reconstitute BCR signaling in Sykdeficient B cells 13 . In addition, Syk apparently could effect TCR-signaling in patients deficient in ZAP-70 14 . However, it is not known whether ZAP-70 protein is expressed in CLL, let alone capable of undergoing phosphorylation or association with the CLL BCR complex upon surface Ig ligation.
In the present study we examined purified CLL B cells for expression of ZAP-70 protein and examined whether ZAP-70 potentially could play a role in BCR signal transduction.
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Materials and Methods
Cell Isolation -Blood samples were collected from consenting patients who satisfied diagnostic and immunophenotypic criteria for common B cell CLL 15 . The patients were not previously treated and had not received recombinant growth factors or exogenous cytokines. Blood mononuclear cells were isolated by density-gradient centrifugation over Ficoll-Hypaque (Pharmacia, Uppsala, Sweden). Cells were suspended in fetal bovine serum (FBS) containing 5% dimethyl sulfoxide for storage in liquid nitrogen. The viability of the CLL cells was 85% at the initiation of culture, as determined by flow cytometric analyses of cells stained with 5 µg/ml propidium iodide (PI; Molecular Probes, Eugene, OR) for 15 minutes at 37°C. All samples contained more than 90% CLL B cells, as assessed by flow cytometric analyses.
Flow cytometry -The cells were stained with mAbs conjugated with either fluorescein, phycoerythrin, allophycocyanin, or Cy-Chrome™ (BD PharMingen, La Jolla, CA) for direct, four-color, multiparameter flow cytometry using a FACS-Calibur™ (BectonDickinson, San Jose, CA), as described 16 . The fluorescence intensity of each stained cell population was compared with that of the same populations treated instead with an isotype control, fluorochrome-conjugated mAb of irrelevant specificity. To measure for expression of CD38, we calculated the median fluorescence intensity ratio (MFIR). This is the ratio of the median fluorescence intensity of gated CD19 Immune Precipitation and Immunoblotting -The protein concentration of each cell lysate was determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, CA).
Ten µg of total cell lysate were loaded onto 10% SDS polyacrylamide gels for electrophoresis. The size-separated proteins were transferred to Immobilon-P transfer membranes. Membranes were blotted with primary antibody at 4 o C overnight or at room temperature for 2 hours. For analysis of phosphotyrosine proteins we used the phosphotyrosine-specific mAb 4G10 (Upstate Biotechnology, Lake Placid, NY). We incubated the blots with secondary antibodies that were conjugated with horseradish peroxidase for 1 hour at room temperature. Blots then were washed and prepared for enhanced chemiluminescence and subsequent autoradiography using Super RX film
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Defined sections of the film were scanned for density measurements using a Scanmaker IISP (Microtek) that were analyzed using NIH Image software. To report the change in signal intensity following stimulation, we subtracted 1 from the ratio of signal intensity of the defined section for the stimulated sample over that of the same sample before stimulation and multiplied this number by 100 to derive the percent change in signal intensity.
For immune precipitation studies, we incubated the lysates of 0. 
Results

ZAP-70 expression in CLL B cells
We examined the leukemia B cells from 22 patients with CLL for expression of A high proportion of cases expressed the V H 1-69 gene that prior studies had identified as being expressed at high frequency in B cell CLL 1, 19 . Two of the patients who had leukemia cells with mutated Ig V genes (CLL16 and CLL17) were monozygous twins who were concordant for CLL. Both twins were diagnosed at the age of 57 after they incidentally were found to have a leukocytosis of approimately 12,000/mm 3 
Functional Analyses of BCR Signaling
We examined whether ligation of the BCR could induce tyrosine phosphorylation of cytosolic proteins in the CLL cases examined for expression of ZAP-70. Each of the freshly thawed leukemia cell samples had comparable expression of surface IgM, allowing us to use anti-µ F(ab) 2 (abbreviated as "anti-µ") as an agonist to effect BCR signaling (data not shown). We found that ligation of the BCR on CLL cell samples that + cases CLL1 ("1) and CLL2 ("2") are compared with those of CLL13 ("13") and CLL14 ("14") in the left panel. Lysates from samples obtained from monozygous twins, CLL16 ("16") and CLL17 ("17"), but that were discordant for expression of ZAP-70, are provided in the right panel. Molecular weight markers are indicated on the left and right margins. The brackets define the areas between 70-72 kDa in size that were scanned for density using NIH image software. The blots were stripped and then probed with anti--actin to monitor for uniformity of protein loading (bottom row labeled as " -actin" on the right-hand margin. Stripping the blots and then re-probing them for Syk revealed that each of the 10 studied cases had similar amounts of Syk protein ( Figure 5A , lower panel).
For However, in this study we found that the association between the use of non-mutated Ig genes and expression of ZAP-70 was not absolute, in that one of the CLL samples that expressed mutated Ig receptors also expressed high-levels of the T-cell receptor PTK.
Nevertheless, we note that a significantly higher proportion of the 12 cases with nonmutated Ig genes expressed ZAP-70 (100%) than did the ten cases with mutated Ig receptors (10%) (P < 0.01).
High-level expression of CD38 correlated with expression of ZAP-70. CD38 is a 45 kD type II transmembrane glycoprotein with ecto-enzymatic activity [20] [21] [22] , which has been argued to play a complex role in B cell activation and proliferation 23 . CLL-cell expression of CD38 has been associated with the use of non-mutated Ig V genes and more aggressive clinical disease 2, 24 . However, similar to other studies 25 , we found that the expression of CD38 was not invariably associated with Ig mutational status. Indeed, one of the samples that expressed mutated Ig V genes (CLL16) also expressed CD38. The use of samples obtained from monozygotic twins concordant for CLL allowed us to examine for differences in leukemia cell populations that likely are due to somatic events. The CLL cells from both twins expressed mutated Ig V H genes of the V H 3 subgroup, but were discordant for expression of ZAP-70 and CD38. Because these twins were monozygous, this analysis suggests that the differences between patients in leukemia-cell expression of ZAP-70 and/or CD38 in CLL cannot be explained by genetic polymorphism.
We found that leukemia cell samples that expressed ZAP-70 had a greater increase in tyrosine phosphorylation following BCR-ligation than did leukemia cell samples lacking expression of ZAP-70. Prior studies demonstrated that CLL cases were heterogeneous in their ability to respond to BCR cross-linking 26, 27 . Furthermore, CLL cells that expressed CD38 appeared more responsive to BCR-ligation 28 . This association between CD38 and signaling intensity also was observed in the leukemia cell samples examined in this study. However, this just may be a reflection of the noted association between CD38 and expression of ZAP-70. All cases that expressed ZAP-70 were noted to have an increase in tyrosine phosphorylation following BCR-ligation.
Moreover, the extent of the average BCR-induced increase in signal intensity for ZAP-70 cases was significantly higher than that noted for samples that did not express ZAP-70, even in ZAP-70 + cases that had negligible expression of CD38 (Figure 4) .
One of the proteins that is phosphorylated after BCR-ligation is Syk. Syk is an important PTK in the BCR-signaling pathway 12, 29, 30 . Prior studies noted that the CLL cells of different patients varied in the extent to which Syk was phosphorylated following BCR-ligation 31, 32 . Moreover, the extent to which Syk underwent tyrosineFor personal use only. on September 14, 2017. by guest www.bloodjournal.org From phosphorylation appeared to be associated with the ability of the leukemia cells to respond to BCR-ligation 32 . However, as noted in this and a prior study 32 , the differences between CLL cases in the levels of Syk phosphorylation following BCRligation were not apparently related to differences in the levels of Syk protein found in each of the CLL cell populations. Instead, we found that the leukemia cells that were better able to respond to BCR-ligation expressed ZAP-70 in addition to Syk. Moreover, the average level of BCR-induced Syk phosphorylation in such cases was significantly greater than that observed in cases that did not express ZAP-70. 
